Genentech Executive and Leadership Team

Ashley Magargee, the Chief Executive Officer at Genentech, directs the company's overarching strategy and operational execution. Magargee guides the organization's mission to develop innovative therapies for serious medical conditions, ensuring alignment with Genentech's commitment to advancing patient outcomes. This leadership role involves setting strategic priorities, fostering a culture of scientific excellence, and driving the company's growth within the competitive biotechnology landscape. Magargee oversees all major business units, ensuring that research and development efforts translate into impactful biopharmaceutical solutions. The Chief Executive Officer's focus remains on maximizing the company's market impact and solidifying its position as a leader in healthcare innovation. Ashley Magargee's strategic vision shapes the company's direction, emphasizing a dedication to improving lives through cutting-edge science and development.

Matty Hackim, the Chief Financial Officer, Solid Tumor Squad at Genentech, manages the financial strategy and fiscal operations for the company's solid tumor therapeutic area. Hackim oversees financial planning, budgeting, forecasting, and investment analysis to support the development and commercialization of oncology treatments. This critical role involves ensuring financial discipline, optimizing resource allocation for research and development, and driving financial performance within the solid tumor squad. The Chief Financial Officer's expertise is vital for making informed strategic decisions that advance Genentech's mission in cancer therapy. Matty Hackim's financial acumen directly supports the advancement of innovative treatments for patients battling solid tumors.

Scott Peng, the Chief Operating Officer at Genentech, directs the company's extensive operational infrastructure and manufacturing capabilities. Peng oversees the complex processes involved in biopharmaceutical development and production, ensuring high standards of quality and efficiency. This leadership position involves managing supply chain logistics, optimizing manufacturing workflows, and driving operational excellence across all production sites. The Chief Operating Officer's focus is on scaling operations to meet global demand for Genentech's innovative therapies. Scott Peng's strategic oversight ensures that the company can reliably deliver life-changing treatments to patients worldwide. Peng's operational leadership is fundamental to Genentech's ability to translate scientific breakthroughs into accessible medical solutions.

Cynthia Shafer, the Chief of Staff at Genentech, provides critical strategic support and operational oversight to executive leadership. Shafer manages key initiatives, facilitates cross-functional collaboration, and ensures efficient execution of the company's strategic objectives. This role involves streamlining communication channels, optimizing resource allocation, and driving operational improvements across various departments. The Chief of Staff's responsibilities extend to preparing executive briefings, coordinating board communications, and managing special projects that advance Genentech's mission. Shafer's efforts are vital in maintaining organizational alignment and accelerating the development and delivery of innovative therapies. Cynthia Shafer's operational acumen enhances the effectiveness of the executive team, directly contributing to the company's ability to address serious medical conditions.

Afsaneh Sahavi, the Pharma Technical Operations Hillsboro Chief of Staff at Genentech, spearheads operational strategy and execution within the Hillsboro technical operations division. Sahavi ensures seamless integration of manufacturing processes, quality control, and supply chain management for pharmaceutical production. This role demands meticulous attention to detail in overseeing complex biopharmaceutical operations, driving efficiency, and maintaining stringent quality standards. The Chief of Staff's responsibilities include optimizing workflows, managing cross-functional teams, and supporting strategic initiatives that enhance production capabilities. Afsaneh Sahavi's leadership is crucial for the reliable output of critical therapies from the Hillsboro facility, directly supporting Genentech's mission to improve patient outcomes through advanced biopharmaceuticals.

Jacquelin Harris, the Director, Operations & Administration Chief of Staff at Genentech, manages critical administrative functions and operational support across key departments. Harris ensures efficient resource allocation, streamlines administrative processes, and supports the strategic implementation of operational initiatives. This position involves overseeing day-to-day administrative operations, facilitating communication between leadership and staff, and driving improvements in organizational efficiency. The Chief of Staff's role is integral to maintaining smooth business operations and supporting the company's broader objectives in biopharmaceutical development. Jacquelin Harris's administrative and operational expertise enhances the effectiveness of Genentech's leadership team, contributing to the company's ability to deliver innovative therapies.

Ankita Chitre, the Head Chief Marketing Officer, Steriles, Quality (North America) at Genentech, directs marketing strategies and commercial operations for sterile products and quality assurance within the North American market. Chitre oversees the go-to-market strategies, brand management, and market access initiatives for Genentech's sterile biopharmaceutical offerings. This leadership role involves analyzing market trends, identifying growth opportunities, and ensuring that marketing efforts align with quality standards and regulatory requirements. The Chief Marketing Officer's focus is on driving market penetration and revenue growth for critical sterile therapies. Ankita Chitre's strategic marketing leadership is essential for expanding patient access to Genentech's innovative treatments across North America.

Alexa Hill, the Principal Administrative Business Partner, Chief Marketing Officer. Commercial Portfolio Organization at Genentech, provides comprehensive administrative and strategic support to the Chief Marketing Officer and the commercial portfolio team. Hill manages key administrative functions, facilitates project coordination, and ensures operational efficiency within the marketing organization. This role involves supporting strategic planning, managing executive communications, and optimizing workflows to enhance team productivity. The Business Partner's contribution is essential for the smooth functioning of the commercial portfolio organization, enabling effective market strategies for Genentech's therapies. Alexa Hill's dedicated support ensures that the Chief Marketing Officer can focus on driving commercial success and expanding patient access.

Beatriz Cansino, the Director and Chief of Staff US Medical - Oncology Hematology at Genentech, directs strategic initiatives and operational execution within the US Medical affairs for oncology and hematology. Cansino ensures alignment between medical strategy and clinical operations, facilitating the effective dissemination of scientific information and support for patient care. This leadership position involves managing key projects, optimizing medical team operations, and supporting the development of medical strategies that address unmet needs in oncology and hematology. The Chief of Staff's role is crucial for enhancing the impact of Genentech's medical affairs in these critical therapeutic areas. Beatriz Cansino's operational leadership strengthens Genentech's commitment to advancing cancer treatment and patient outcomes.

Matthias Perczynski, the Chief of Staff Personalized Health Care Ix Head of Strategy at Genentech, drives strategic planning and operational execution for personalized healthcare initiatives. Perczynski focuses on integrating advanced strategies to tailor medical treatments and improve patient outcomes through personalized approaches. This role involves developing and implementing innovative strategies, fostering cross-functional collaboration, and ensuring that personalized healthcare solutions align with Genentech's broader mission. The Chief of Staff's leadership is vital for advancing the company's capabilities in precision medicine and enhancing patient care. Matthias Perczynski's strategic direction shapes the future of personalized healthcare at Genentech, reinforcing the company's commitment to cutting-edge therapeutic development.